why do glp 1 agonists cause pancreatitis GLP-1 Receptor as Treatments for Type 2 Diabetes GLP-1 agonists-induced autoimmune pancreatitis |
Description
Lancet Neurol 14(3):329340 Biessels GJ, Verhagen C, Janssen J et al (2019) Effect of linagliptin on cognitive performance in patients with type 2 diabetes and cardiorenal comorbidities: the CARMELINA randomized trial
GLP-1 was identified as a key incretin hormone in the 1980 s (Lund et al
BY REGION The GLP-1 agonists market covers North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
10.1074/jbc.274.48.33851 13 ButeauJ.RoduitR.SusiniS.PrentkiM
J Am Dent Assoc
Separate large scale clinical trials totaling over 450,000 participants demonstrate there are significant reductions in dementia incidence for individuals using GLP-1 medications based upon hazard ratio data
